TIZIMLI QIZIL YUGURUKDA ANEMIYA RIVOJLANISHINING IMMUNOLOGIK VA GEMATOLOGIK MEXANIZMLARI
Keywords:
tizimli qizil yuguruk, anemiya, autoimmun gemoliz, gepsidin, interleykin-6, ferritin, komplement, eritropoezAbstract
Tizimli qizil yuguruk (TQY) ko‘p a’zoli autoimmun kasallik bo‘lib, unda anemiya yallig‘lanish, autoantitanalar, komplement faollashuvi, buyrak shikastlanishi, temir almashinuvi buzilishi va dori vositalari ta’siri bilan bog‘liq turli mexanizmlar natijasida yuzaga keladi. Ushbu maqolaning maqsadi TQYda anemiyaning immunologik va gematologik asoslarini ilmiy adabiyotlar bo‘yicha tizimlashtirish hamda differensial diagnostikaga oid amaliy algoritmni taklif etishdan iborat. Tadqiqot narrativ-tahliliy adabiyotlar sharhi shaklida bajarildi. Tahlil natijalariga ko‘ra, surunkali yallig‘lanish anemiyasi, temir tanqisligi, autoimmun gemolitik anemiya va buyrak kasalligi bilan bog‘liq anemiya bir-biri bilan qo‘shilib kelishi mumkin. Retikulotsitlar, ferritin, transferrin to‘yinishi, gemoliz markerlari, komplement va buyrak funksiyasini birgalikda baholash muhimligi asoslandi. Maqoladagi jadvallar adabiyotlar sintezi bo‘lib, original bemorlar ma’lumotlarini ifodalamaydi.
References
Tsokos, G. C. (2011). Systemic lupus erythematosus. New England Journal of Medicine, 365(22), 2110–2121. https://doi.org/10.1056/NEJMra1100359
Aringer, M., et al. (2019). 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Annals of the Rheumatic Diseases, 78, 1151–1159. https://doi.org/10.1136/annrheumdis-2018-214819
Voulgarelis, M., Kokori, S. I., Ioannidis, J. P. A., Tzioufas, A. G., Kyriaki, D., & Moutsopoulos, H. M. (2000). Anaemia in systemic lupus erythematosus: Aetiological profile and the role of erythropoietin. Annals of the Rheumatic Diseases, 59, 217–222.
Giannouli, S., Voulgarelis, M., Ziakas, P. D., & Tzioufas, A. G. (2006). Anaemia in systemic lupus erythematosus: From pathophysiology to clinical assessment. Annals of the Rheumatic Diseases, 65, 144–148. https://doi.org/10.1136/ard.2005.041673
Crow, M. K. (2014). Type I interferon in the pathogenesis of lupus. Journal of Immunology, 192, 5459–5468. https://doi.org/10.4049/jimmunol.1002795
Weiss, G., & Goodnough, L. T. (2005). Anemia of chronic disease. New England Journal of Medicine, 352, 1011–1023. https://doi.org/10.1056/NEJMra041809
Ganz, T. (2019). Anemia of inflammation. New England Journal of Medicine, 381, 1148–1157. https://doi.org/10.1056/NEJMra1804281
Fanouriakis, A., et al. (2024). EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Annals of the Rheumatic Diseases, 83, 15–29. https://doi.org/10.1136/ard-2023-224762
Camaschella, C. (2015). Iron-deficiency anemia. New England Journal of Medicine, 372, 1832–1843. https://doi.org/10.1056/NEJMra1401038
Nemeth, E., et al. (2004). IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. Journal of Clinical Investigation, 113, 1271–1276. https://doi.org/10.1172/JCI20945
Hill, Q. A., et al. (2017). The diagnosis and management of primary autoimmune haemolytic anaemia. British Journal of Haematology, 176, 395–411. https://doi.org/10.1111/bjh.14478
Kidney Disease: Improving Global Outcomes (KDIGO) Lupus Nephritis Work Group. (2024). KDIGO 2024 clinical practice guideline for the management of lupus nephritis. Kidney International, 105(1S), S1–S69.
Fava, A., & Petri, M. (2019). Systemic lupus erythematosus: Diagnosis and clinical management. Journal of Autoimmunity, 96, 1–13. https://doi.org/10.1016/j.jaut.2018.11.001
O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi. (2024). Klinik protokollar va standartlar: Revmatologiya yo‘nalishi. Rasmiy axborot resursi: https://ssv.uz/
O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi. (2024). Klinik protokollar va standartlar: Gematologiya yo‘nalishi. Rasmiy axborot resursi: https://ssv.uz/





